bromocriptine has been researched along with Idiopathic Parkinson Disease in 612 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 361 (58.99) | 18.7374 |
1990's | 143 (23.37) | 18.2507 |
2000's | 83 (13.56) | 29.6817 |
2010's | 21 (3.43) | 24.3611 |
2020's | 4 (0.65) | 2.80 |
Authors | Studies |
---|---|
Bagli, J; Bogri, T; Voith, K | 1 |
Ali, J; Baboota, S; Dang, S; Kumar Sahoo, P; Nigam, K; Usama Ashhar, M; Vohora, D; Vyas, P | 1 |
Akhtar, MF; Akter, R; Al-Harrasi, A; Berrada, M; Bhatia, S; Damiri, F; Ferdous Mitu, J; Kabir, MT; Rahman, MH; Rahman, MS; Saleem, A | 1 |
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C | 1 |
Ali, J; Ashhar, MU; Baboota, S; Kumar, S | 1 |
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C | 1 |
Michael Besser, G; Pfeiffer, RF; Thorner, MO | 1 |
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ | 1 |
Cautres, M; Cautres, T; Mohty, D | 1 |
Chen, HB; Li, SH; Ma, J; Sun, XR; Tang, RH; Wang, ZF; Yang, JS; Zhang, XY; Zhao, WQ | 1 |
Baxter, LR; Chandra, A; Kamrowski, K; Nguyen, T; Prokai, D; Prokai, L; Talamantes, T | 1 |
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T | 1 |
Ali, J; Baboota, S; Fazil, M; Haque, S; Kumar, M; Md, S; Sahni, JK | 1 |
Ali, F; Fatima, A; Jyoti, S; Khan, W; Khanam, S; Naqvi, AH; Naz, F; Siddique, YH; Singh, BR | 1 |
Becu-Villalobos, D; Brie, B; Garcia Tornadu, I; Lopez Vicchi, F; Luque, GM; Nogueira, JP | 1 |
Broderick, PA; Li, YS; Wenning, L | 1 |
Ben-Shlomo, Y; Evans, A; Head, J; Katzenschlager, R; Lees, AJ; Schrag, A | 1 |
Au, WL; Chan, YH; Lee, RK; Ng, KK; Tan, LC; Tan, NC | 1 |
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C | 1 |
Boo, DH; Choi, HJ; Hwang, O; Kang, BY; Kim, EM; Kim, SS; Lim, JH; No, H | 1 |
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S | 1 |
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H | 1 |
Pullan, PT | 1 |
Montgomery, EB | 1 |
Chacun, H; Farinotti, R; Fernandez, C; Lacomblez, L; Milane, A; Vautier, S | 1 |
Awa, Y; Hattori, T; Higuchi, Y; Ichikawa, T; Ito, T; Kobayashi, M; Kuwabara, S; Sakakibara, R; Uchiyama, T; Yamaguchi, C; Yamamoto, T; Yamanishi, T; Yanagisawa, M; Yano, M | 1 |
Schneemilch, C | 1 |
Lee, MR | 1 |
Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG | 1 |
Au, WL; Lee, RK; Ng, KK; Tan, LC; Tan, NC | 1 |
Assaggaf, S; Azzouni, H; Houissa, S; Mustapha, ME; Rebai, RM | 1 |
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E | 1 |
Asselman, P; Debono, AG; Marsden, CD; Parkes, JD | 1 |
Kumar, JB; Luthra, PM | 1 |
Bamia, C; Kenward, MG; White, IR | 1 |
Ali, J; Baboota, S; Chuttani, K; Khan, RA; Md, S; Mustafa, G; Sahni, JK | 1 |
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H | 1 |
Hauser, RA; Holford, NH | 1 |
Kondo, T | 1 |
Gekht, AB | 1 |
Kuhlmann, A; Müller, T; Reimer, J | 1 |
Cho, IS; Ha, JH; Im, JH; Lee, MC | 1 |
Quinn, NP | 1 |
Han, SY; Ratnagopal, P; Tan, EK; Wong, MC | 1 |
Lai, BC; Marion, S; Schulzer, M; Teschke, K; Tsui, JK | 1 |
Beier, KM; Berger, Ch; Mehrhoff, FW; Meinck, HM | 1 |
Bagheri, H; Montastruc, JL; Schmitt, L | 1 |
Atsumi, M; Iga, T; Kawakami, J; Kotaki, H; Sato, H; Sawada, Y; Sugiyama, E; Yamada, Y | 1 |
Okamoto, K; Tanaka, M | 1 |
Hasegawa, K; Kowa, H; Kuno, S; Mizuno, Y; Origasa, H; Yamamoto, M; Yanagisawa, N | 1 |
Lang, AE; Razmy, A; Shapiro, CM | 1 |
Araki, I; Kuno, S; Mizuta, E; Yamasaki, S | 1 |
Hotta, M; Kamo, T; Kawakami, M; Nemoto, S; Oshima, J; Shimojo, S; Shiraishi, M; Sugihara, H; Takahashi, Y; Yasaki, S | 1 |
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
Grosset, D; Grosset, K; Macphee, G; Needleman, F | 1 |
Clarke, CE; Deane, KH; Spieker, S | 1 |
Basu, S; Chaudhuri, KR; Dhawan, V; Jackson, G; Odin, P | 1 |
Hely, MA; Morris, JG; Reid, WG; Trafficante, R | 1 |
Hoffmann, A; Klotz, P; Kraus, PH; Lewe, J; Przuntek, H | 1 |
Jost, WH | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Aley-Medina, P; Avila-Costa, MR; Colín-Barenque, L; Fortoul, TI; Librado, JL; Martínez, EF; Martínez, VA; Montiel-Flores, E; Mussali-Galante, P; Valdez, AL | 1 |
Aguilar, M; Castro-Caldas, A; Cesaro, P; Del Signore, S; Delwaide, P; Jost, W; Lamberti, P; Merello, M; Williams, A | 1 |
Azouvi, P; Ben Smaïl, D; Régnault, J; Rouy-Thenaisy, K; Samuel, C | 1 |
Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G | 1 |
Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I | 1 |
Chung, EJ; Kim, JY; Lee, WY; Park, SW | 1 |
Turnbull, GI | 1 |
Marvanova, M; Nichols, CD | 1 |
Lindh, J | 1 |
Ives, NJ; Ramaker, CC; Stowe, R; van Hilten, JJ | 2 |
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
Choi, HJ; Hwang, O; Kim, KM; Kim, SW; Lim, JH | 1 |
Burton, K; Calne, DB | 1 |
Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF | 1 |
Angrist, B; Lieberman, A; Serby, M | 2 |
Calne, DB; Eisler, T; Gopinathan, G; Williams, A | 1 |
Lees, AJ; Stern, GM | 3 |
Besser, GM; Wass, JA | 1 |
Hallett, M | 1 |
König, MP | 1 |
Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG | 1 |
de Fine Olivarius, B; Dupont, E; Strong, MJ | 1 |
Larsen, TA; Teräväinen, H | 1 |
Weiner, M | 1 |
Duvoisin, RC; Heikkila, RE; Manzino, L | 1 |
Willner, P | 1 |
Kurako, IuL; Volianskiĭ, VE | 1 |
Chamontin, B; Montastruc, JL; Rascol, A | 2 |
Jellinger, K | 1 |
Fischer, PA; Schneider, E | 2 |
Jörg, J | 1 |
Biesemeyer, H; Ludin, HP; Ringwald, E | 1 |
Calne, DB; Eisler, T; Hall, RP; Kalavar, KA | 1 |
Abensour, P; Agid, Y; Bonnet, AM; Jouvent, R; Lhermitte, F; Widlocher, D | 1 |
Evans, WS; Thorner, MO; Vance, ML | 1 |
Beckman, J; Burton, K; Calne, DB; Martin, WR | 1 |
Destee, A | 1 |
Montastruc, JL; Rascol, A | 1 |
Rinne, UK | 9 |
Laakso, K; Laihinen, A; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK | 1 |
Burns, RS; Calne, DB; LeWitt, PA | 1 |
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD | 1 |
Fischer, PA; Majer, M; Przuntek, H; Welzel, D | 1 |
Chong, PN; Devathasan, G; Lun, KC; Puvanendran, K; Wong, PK | 1 |
Feely, J; Paterson, CR | 1 |
Birkmayer, W; Danielczyk, W; Jellinger, K; Koppel, H; Reynolds, GP; Riederer, P; Seemann, D; Ulm, G | 1 |
von Werder, K | 1 |
Bihari, K; Csanda, E; Köves, A; Mogyorós, I; Takáts, A; Tárczy, M | 1 |
Alonso, RJ; Covington, TR; Mancall, EL | 1 |
Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L | 1 |
Lancranjan, I | 1 |
Borowski, GD; Rose, LI | 1 |
Morris, JG | 3 |
Bouchard, S; Grimes, JD; King, DB; Kofman, OS; Molina-Negro, P; Wilson, AF | 1 |
Login, IS | 1 |
Calne, DB; Larsen, TA; LeWitt, P; Newman, R | 1 |
Lustig, A | 1 |
Fischer, PA; Hubener, K; Schneider, E | 2 |
Schiffter, R; Vogel, HP | 1 |
Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G | 2 |
Lipcsey, A; Peres, A | 1 |
Grimes, JD | 2 |
Montastruc, JL; Rascol, A; Rascol, O | 3 |
Goldstein, M; Gopinathan, G; Hassouri, H; Lieberman, AN; Neophytides, A | 1 |
Calne, DB; Newman, RP | 1 |
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N | 1 |
Bouchard, S; Grimes, JD; Jones, MW; Kofman, OS; Molina-Negro, P | 1 |
Ledić, P; Sepcić, J | 1 |
Bear, G; Casson, I; Durso, R; Foo, SH; Goldstein, M; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A | 1 |
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
Calne, DB; Gopinathan, G | 1 |
Allain, H; Bentue-Ferrer, D; Pape, D; Reymann, JM; Sabouraud, O; van den Driessche, J | 1 |
Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO | 1 |
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R | 1 |
Ford, J; Jackson, JA; Jankovic, J | 1 |
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R | 1 |
Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Toone, B | 1 |
Grimes, JD; Hassan, MN | 2 |
Delwaide, PJ; Schoenen, J | 1 |
Hopkins, S | 1 |
Friis, ML; Grøn, U; Pakkenberg, H | 1 |
Besset, A; Passouant, P | 1 |
Calne, DB; Teräväinen, H | 1 |
Calne, DB; Le Witt, PA | 1 |
Glantz, R; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA | 1 |
Goetz, CG; Nausieda, PA; Tanner, CM | 1 |
Calne, DB; Dambrosia, JM; Durso, R; Gopinathan, G; LeWitt, PA; Sanes, JN; Ward, CD | 1 |
Hirt, D; Markstein, R; Ringwald, E; Vigouret, JM | 1 |
Haas, JA; Lakke, JP | 1 |
Muenter, MD | 2 |
Klawans, HL | 1 |
Gauthier, G; Martins da Silva, A | 1 |
Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ | 1 |
Clanet, M; Guiraud-Chaumeil, B; Montastruc, JL; Rascol, A | 1 |
Jeske, W | 1 |
Chapler, FK; Sherman, BM | 1 |
Pentland, B; Sawers, JS | 1 |
Calne, DB; Dambrosia, JM; Evarts, EV; Gopinathan, G; Sanes, JN; Stuart, WK; Teräväinen, H; Ward, CD | 1 |
Agid, Y; Illas, A; Lhermitte, F; Quinn, N | 2 |
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B | 1 |
Lieberman, AN; Plasse, HM | 1 |
Jacquin-Cotton, L; Martini, L; Ndiaye, IP | 1 |
Ulm, G | 1 |
Agid, Y; Lhermitte, F; Quinn, N | 1 |
Stewart, RM | 1 |
Hoehn, MM | 2 |
Bøttcher, J; Grøn, U | 1 |
McGregor, AM | 1 |
Caraceni, T; Giovannini, P; Girotti, F; Parati, E; Pederzoli, M; Scigliano, G | 1 |
Casson, I; Durso, R; Foo, SH; Goldstein, M; Gopinathan, G; Khayali, M; Kupersmith, M; Lieberman, AN; Neophytides, A; Tartaro, T | 1 |
Barrett, RE; Côté, LJ; Fahn, S; Snider, SR | 1 |
Godwin-Austen, RB | 1 |
Lander, CM; Lees, AJ; Shaw, KM; Stern, GM | 1 |
Duvoisin, RC; Mendoza, MM; Yahr, MD | 1 |
Bédard, P; Debono, AG; Dorow, R; Horowski, R; Jenner, P; Keenan, J; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J; Schachter, M; Smith, B | 1 |
Friis, ML; Hvidberg, EF; Johnsen, T; Larsen, NE; Pakkenberg, H | 1 |
Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP | 1 |
Kawakami, H; Nakamura, S; Tanaka, K; Yamashita, H; Zhang, YX | 1 |
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW | 1 |
Eadie, MJ | 1 |
Ludin, HP | 1 |
Clinnick, S; Fonda, D; Schwarz, J | 1 |
Janjua, R; Roos, RA; van Kempen, GM | 1 |
Boyd, A | 1 |
Danysz, W; Quack, G; Rogoz, Z; Skuza, G | 1 |
Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
Mark, MH; Sage, JI | 1 |
Ogawa, N | 2 |
Goto, I; Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N | 3 |
Gsell, W; Lange, KW; Naumann, M; Oestreicher, E; Rausch, WD; Riederer, P | 1 |
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O | 1 |
Silverman, PB | 1 |
Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T | 1 |
Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G | 1 |
Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM | 1 |
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM | 1 |
Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
Yanagisawa, N | 2 |
Dichgans, J; Klockgether, T | 1 |
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR | 1 |
Lauterbach, EC | 1 |
Cooper, JA; Sagar, HJ; Sullivan, EV | 1 |
Comella, CL; Ristanovic, RK; Tanner, CM | 1 |
Klockgether, T; Löschmann, PA; Schugens, MM | 1 |
Lieberman, A | 2 |
Rumbach, L; Tranchant, C; Viel, JF; Warter, JM | 1 |
Factor, SA; Weiner, WJ | 1 |
Kuno, S | 2 |
Yoshikawa, T | 1 |
Chanter, DO | 1 |
Kornhuber, J; Weller, M | 1 |
Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ | 1 |
Filipovic, S; Kostic, VS; Marinkovic, Z; Momcilovic, D | 1 |
Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G | 1 |
Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M | 1 |
Montastruc, JL; Rascol, O; Senard, JM | 3 |
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I | 1 |
Lees, AJ | 2 |
Angulo Cuesta, J; Guil Cid, M; Jiménez, FJ; López Alvarez, YJ; Sánchez-Chapado, M | 1 |
Calzetti, S; Cassio, A; Negrotti, A | 1 |
Ahlskog, JE | 1 |
Kishore, A; Snow, BJ | 1 |
Klaassen, RJ; Krepel, HP; Troost, RJ; van der Lely, AJ; Verhoeven, GT | 1 |
Benabid, AL; Benazzouz, A; Hoffmann, D; Limousin, P; Perret, JE; Pollak, P | 1 |
Akiguchi, I; Fukuyama, H; Imai, T; Kawamura, J; Kimura, J | 1 |
Bastos-Lima, A; Castro-Caldas, A; Coelho, T; Levy, A; Sampaio, C | 1 |
Dierks, T; Grosse, H; Kuhn, W; Müller, T; Rommelspacher, H | 1 |
Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM | 1 |
Catz, T; Inzelberg, R; Kippervasser, S; Korczyn, AD; Nisipeanu, P; Orlov, E; Rabey, JM; Schechtman, E | 1 |
Blümner, E; Danielczyk, W; Gerlach, M; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Uberla, K; Welzel, D | 1 |
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A | 1 |
Burguera, JA; Chacón, J; Forcadell, F; Giménez-Roldán, S; Liaño, H; Tolosa, E | 1 |
Korczyn, AD; Nisipeanu, P | 1 |
Mizuno, Y; Yanagisawa, N | 1 |
Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P | 1 |
Giménez-Roldán, S; Mateo, D | 1 |
Guttman, M | 1 |
Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R | 1 |
Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N | 1 |
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF | 1 |
Brefel, C; Lapeyre-Mestre, M; Montastruc, JL; Raï, S; Rascol, A; Rascol, O; Senard, JM | 1 |
Brooks, DJ; Brunt, ER; Korczyn, AD; Poewe, WH; Rascol, O; Stocchi, F | 1 |
Alegre, M; Martínez Lage, JM; Noé, E | 1 |
Marsden, CD | 1 |
Blomkvist, A; Hillerdal, G; Koyi, H; Lee, J; Rask-Andersen, A; Rasmussen, E; Uddenfeldt, M | 1 |
De Vuyst, P; Gevenois, PA; Knoop, C; Lenclud, C; Mairesse, M | 1 |
Abrams, KR | 1 |
Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Lees, AJ; Ockelford, J; Overstall, P | 1 |
Amano, K; Takakura, K | 1 |
Benito-León, J; Bermejo, F; Porta-Etessam, J | 1 |
Factor, SA | 1 |
Brunt, ER; Korczyn, AD; Larsen, JP; Nagy, Z; Poewe, WH; Ruggieri, S | 1 |
Weiner, WJ | 1 |
Miyoshi, T; Motomura, S; Osoegawa, M; Tamura, K; Yamanaka, H | 1 |
Balmes, P; Blayac, JP; Champagne, S; Coste, E; Davy, JM; Hillaire-Buys, D; Mania, E; Nigond, J; Peyrière, H; Pons, M | 1 |
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S | 1 |
Antonini, A; Barichella, M; Canesi, M; Mariani, CB; Pezzoli, G; Tesei, S; Zecchinelli, AL | 1 |
Barbanoj, M; Casas, M; Jané, F; Kulisevsky, J; Prat, G; Robledo, P | 1 |
Finken, MJ; Ramaker, C; van de Beek, WJ; van Hilten, BJ | 1 |
Ferreira, JJ; Galitzky, M; Montastruc, JL; Rascol, O | 1 |
Clarke C, E; Speller J, M | 1 |
Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ | 1 |
Clarke, CE; Speller, JM | 1 |
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW | 1 |
Clarke, CE; Deane, KH | 2 |
Clarke C, E; Clarke J, A; Speller J, M | 1 |
Ramaker, C; van Hilten, JJ | 1 |
Bulckaen, H; Devulder, B; Fauchais, AL; Hachulla, E; Hatron, PY; Michon-Pasturel, U; Queyrel, V | 1 |
Asanuma, M; Ogawa, N; Tanaka, K | 1 |
Hasegawa, K | 1 |
Haapaniemi, TH; Kallio, MA; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U | 1 |
Sternon, J; Supiot, F; Zegers de Beyl, D | 1 |
Clarke, CE; Deane, KD | 1 |
Bizzarri, G; Calzetti, S; Negrotti, A | 1 |
Haapaniemi, TH; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U | 1 |
Chew, EL; Ong, KC; Ong, YY | 1 |
Brefel-Courbon, C; Desboeuf, K; Lapeyre-Mestre, M; Montastruc, JL; Rascol, O; Senard, JM | 1 |
Jankovic, J; Le, WD | 1 |
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
Debove, P; L'Her, P; Renard, JL; Simon, F; Vaylet, F | 1 |
Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR | 1 |
Fukui, T; Hira, K; Shimbo, T; Takemura, M | 1 |
Ben-Shlomo, Y; Head, J; Katzenschlager, R; Lees, AJ | 1 |
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M | 1 |
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F | 1 |
Keens, J; Schrag, A; Warner, J | 1 |
Bittkau, S; Bliesath, H; Büttner, U; Fuchs, G; Glass, J; Haller, H; Klockgether, T; Kraus, P; Lachenmayer, L; Müller, D; Müller, T; Przuntek, H; Rathay, B; Sgonina, J; Steinijans, V; Teshmar, E; Ulm, G; Volc, D | 1 |
Hilten, JJ; Ramaker, C | 1 |
Winkelman, AC | 1 |
Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S | 1 |
Hungerbühler, JP; Regli, F | 1 |
Calne, DB; Eisler, T; Neophytides, A; Nutt, JG; Teychenne, PF; Williams, AC | 1 |
Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN | 2 |
Parkes, JD | 1 |
Przuntek, H | 1 |
Lees, AJ; Shaw, KM; Stern, GM | 2 |
Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD | 1 |
Hayes, S; Lees, AJ; Ross, EJ; Shaw, KM; Stern, GM; Thompson, BD | 1 |
Debono, AG; Marsden, CD; Parkes, JD | 2 |
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P | 1 |
Lipper, S | 1 |
Duvoisin, RC | 1 |
Marsden, CD; Parkes, JD | 1 |
Calne, DB; Neophytides, A; Nutt, JG; Plotkin, C; Teychenne, PF; Williams, AC | 1 |
Glaubman, H; Rabey, JM; Streifler, M; Vardi, J | 1 |
Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Agid, Y; Bonnet, AM; Lhermitte, F; Pollak, P; Signoret, JL | 1 |
Blackstock, J; Dick, JP; George, RJ; Marsden, CD; Parkes, JD; Schachter, M | 1 |
Daggett, P; Franks, S; Lees, AJ; Shaw, KM; Stern, GM; Thompson, BD | 1 |
Lander, CM; Lees, A; Stern, G | 1 |
Calne, DB; Carter, AC; Chase, TN; Kartzinel, R; Perlow, MD; Shoulson, I | 1 |
Rosa, A | 1 |
Calne, DB; Kartzinel, R; Shoulson, I | 3 |
Andreoli, VM; Frattola, L; Spano, PF; Trabucchi, M | 1 |
Hill, JW | 1 |
Casson, I; Durso, R; Foo, SH; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A; Tartaro, T | 1 |
Godwin-Austen, RB; Smith, NJ | 1 |
Gron, U | 1 |
Hansen, E; Kristensen, O | 1 |
Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A | 1 |
Parkes, D | 2 |
Jansen, EN | 1 |
Agnoli, A; Casacchia, M; Ruggieri, S | 1 |
Pearce, I; Pearce, JM | 2 |
Debono, A; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J | 1 |
Bateman, DN; Coxon, A; Legg, NJ; Reid, JL | 1 |
Lance, JW; Mackenzie, RA | 2 |
Berde, B | 1 |
Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL | 1 |
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E | 1 |
Baba, Y; Miyamoto, T; Ohmoto, T | 1 |
Marx, JL | 1 |
Clanet, M; David, J; Guiraud, B; Montastruc, JL; Rascol, A | 1 |
Bender, DA; Earl, CJ; Lees, AJ | 1 |
Friis, ML; Grøn, U; Hvidberg, EF; Larsen, NE; Pakkenberg, H | 1 |
Glaubman, H; Rabey, I; Vardi, J | 1 |
Glaubman, H; Rabey, J; Streifler, M; Vardi, J | 2 |
Allelov, M; Flechter, S; Hertzberg, M; Oberman, Z; Rabey, JM; Streifler, M; Vardi, J | 1 |
Besset, A; Billiard, M; Bonardet, A; Descomps, B; Nègre, C; Passouant, P | 1 |
Hvidberg, EF; Larsen, NE; Larsson, M; Ohman, R | 1 |
Kanapa, DJ; Klawans, HL; Nausieda, PA; Weiner, WJ | 1 |
Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Snider, SR | 1 |
Klawans, HL; Koller, WC; Nausieda, PA; Weiner, WJ | 1 |
Fahn, S; Hutt, CS; Snider, SR | 1 |
Jotkowitz, S | 1 |
Distiller, LA; Joffe, BI; Seftel, HC | 1 |
Agnoli, A; Carolei, A; Masturzo, P; Meco, G; Polleri, A; Rolandi, E | 1 |
Caraceni, TA; Celano, I; Girotti, F; Parati, E | 1 |
Bédard, P; Marsden, CD; Parkes, JD | 1 |
Hyyppä, MT; Långvik, VA; Rinne, UK | 1 |
Pakkenberg, H | 1 |
Calne, DB | 2 |
Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF | 1 |
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM | 1 |
Marttila, R; Rinne, UK | 1 |
Lees, A; Stern, G | 2 |
Yahr, MD | 1 |
Gilligan, B; Stark, R; Wodak, J | 1 |
Gerlach, J | 1 |
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E | 1 |
Marttila, R; Rinne, UK; Sonninen, V | 2 |
Rabey, JM; Streifler, M; Vardy, J | 1 |
Calne, DB; Pfeiffer, RF; Teychenne, PF | 1 |
Calne, DB; Kartznel, R | 1 |
Vaisurb, S | 1 |
Bories, F; Bousser, MG; Conard, J; Samama, M | 1 |
McLellan, DL | 1 |
Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A | 1 |
Agnoli, A; Carolei, A; Casacchia, M; Meco, G; Ruggieri, S; Zamponi, A | 1 |
Dipalma, JR | 1 |
Bories, F; Bousser, MG; Castaigne, P; Laplane, D | 1 |
Calne, DB; Kartzinel, R; Perlow, M; Pfeiffer, R; Teychenne, PF | 1 |
Bassendine, MF; Calne, DB; Claveria, LE; Petrie, A; Teychenne, PF | 1 |
Andre, JM; Jacquier, A; Kissel, P | 1 |
Reid, WG | 1 |
Demedts, M; Dom, R; Frans, E | 1 |
Diederich, NJ; Goetz, CG | 1 |
Mizuno, Y | 1 |
Kraus, PH; Letzel, H; Przuntek, H; Schwarzmann, D; Welzel, D | 1 |
Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nakanishi, T; Nishitani, H; Ogawa, N; Takahashi, A | 6 |
Blümner, E; Danielczyk, W; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Schwarzmann, D; Welzel, D; Wolf, H | 1 |
Andersson, U; Aquilonius, SM; Freccero-Rosman, K; Lindvall, O; Nylander, B; Odin, P | 1 |
Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Riva, R | 1 |
Levivier, M; Przedborski, S | 1 |
Laihinen, A; Rinne, UK; Suchy, I | 1 |
Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P | 1 |
Haas, JA; Jansen, EN; Lakke, JP; Staal-Schreinemachers, A; van der Sande, JJ | 1 |
Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM | 1 |
Grossman, G; Martin, L; Riley, DE | 1 |
Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y | 1 |
Agid, Y; Emre, M; Lataste, X; Lees, A; Rascol, A; Rinne, UK | 1 |
Cooper, JA; Jordan, N; Sagar, HJ | 1 |
Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA | 1 |
Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D | 1 |
Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D | 1 |
Allain, H; Bentue-Ferrer, D; Brunet-Bourgin, F; Chaumet-Riffaud, P; Decombe, R; Gandon, JM; Goulley, F; Le Coz, F; Loria, Y; Reymann, JM | 1 |
Graff, E; Harsat, A; Rabey, JM; Schwartz, M; Vered, Y | 1 |
Aguilar, M; Alió, J; Saura, J | 1 |
Nakashima, K; Takahashi, K | 1 |
Chariá, P; Díaz, F; Liberman, C | 1 |
Bonifati, V; Capriani, C; Cusimano, G; Meco, G | 1 |
Jacobs, MB; Varon, J | 1 |
Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nishitani, H; Ogawa, N; Takahashi, A; Tashiro, K | 1 |
Eriksson, T; Oberg, B; Pedersen, SW | 1 |
Goetz, CG | 1 |
Kleedorfer, B; Poewe, W; Schelosky, L | 1 |
Durrieu, G; Montastruc, JL; Rascol, A; Senard, JM; Tran, MA | 1 |
Genge, S; Hely, MA; Jeremy, R; Lawrence, S; Morris, JG | 1 |
MacMahon, DG; Marshall, T; Overstall, PW | 1 |
Allain, H; Milon, D; Morel, G; Reymann, JM; Sabouraud, O; Van den Driessche, J | 1 |
Guidi, M; Mauro, AM; Mercante, O; Pelliccioni, G; Scarpino, O | 1 |
Edwards, RL; Oliver, WA; Todman, DH | 1 |
Chevalier, C; Collier, A; Hardy, JC; Kains, JP | 1 |
Cowan, A | 1 |
Olsson, JE | 1 |
Becker, AL; Bilchik, TR; Blumenfeld, A; Fourie, PB; Fritz, VU; Ming, A; Reef, HE; Saling, M; Temlett, JA | 1 |
Diot, E; Diot, P; Guilmot, JL; Jonville, AP; Lasfargues, G; Lavandier, M; Le Rolland, A; Lemarie, E | 1 |
Dufresne, JJ | 1 |
Albani, G; Amabile, G; Fattapposta, F; Morocutti, C; Pozzessere, G; Rizzo, PA; Sanarelli, L | 1 |
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W | 1 |
Beurrier, D; Hirsch, E; Kaminsky, P; Kiesman, M | 1 |
Caron, J; Foissac-Gegoux, P; Petit, H; Vermersch, P | 1 |
Moskowitz, C; Winfield, L | 1 |
Bar, M; Graff, E; Isakov, A; Oberman, Z; Rabey, JM; Scharf, M | 1 |
Itoh, H; Kitagawa, M; Ooka, T; Watanabe, A | 1 |
Raphael, V | 1 |
Broe, GA; Genge, S; Hely, MA; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM | 2 |
Selby, G | 1 |
Glatt, S; Hassanein, R; Koller, WC; Vetere-Overfield, B | 1 |
Benabid, AL; Champay, AS; Hommel, M; Perret, JE; Pollak, P | 1 |
Ackermann, H; Oertel, WH; Ziegler, W | 1 |
Carroll, VS; Goetz, CG; Klawans, HL; Shannon, KM; Tanner, CM | 1 |
Villares, JC | 1 |
Calne, D; Hertzman, C; Snow, B; Wiens, M | 1 |
Kinnunen, E; Viljanen, A | 2 |
Dichgans, J; Scholz, E | 1 |
Harvey, NS | 1 |
Bowler, JV; Legg, NJ; Ormerod, IE | 1 |
Huber, M | 1 |
Boyce, S; Jenner, P; Marsden, CD | 1 |
Cummings, JL; Friedenberg, DL | 1 |
Braunstein, GD; Melmed, S | 1 |
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA | 1 |
Christensen, RS | 1 |
Berlan, M; Boneu, B; Caranobe, C; Lafontan, M; Montastruc, JL; Rascol, A; Villeneuve, A | 1 |
Herskovits, E; Leston, J; Yorio, A | 1 |
Laihinen, A; Rinne, UK | 2 |
Baden, DR; Kenny, AM; Murrin, LC; Pfeiffer, RF; Schneider, MB | 1 |
LeWitt, PA | 1 |
Fahn, S; Hassan, MN; Higgins, D; Traub, M | 1 |
Mondal, BK; Mondal, KN | 1 |
Birkmayer, JD; Birkmayer, W | 1 |
Jansen, EN; Meerwaldt, JD | 1 |
Aminoff, MJ | 1 |
Cleeves, L; Findley, LJ | 1 |
Dubuis, R | 1 |
Birkmayer, W | 1 |
Calne, DB; Rinne, UK | 1 |
Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG | 1 |
Churg, A; Fleetham, JA; McElvaney, NG; Wilcox, PG | 1 |
Berecz, G; Diószeghy, P; Glaub, T; Mechler, F; Pintér, N; Virga, A | 1 |
Bouchard, S; Gawel, MJ; King, DB; Libman, I; McLean, DR; Paulseth, R; Raphy, B; Riopelle, RJ | 1 |
Wallis, WE | 2 |
Factor, SA; Sanchez-Ramos, JR; Weiner, WJ | 1 |
Lang, AE | 1 |
Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ | 1 |
Bayes, A; Blesa, R; Forcadell, F; Tolosa, E | 1 |
Allain, H; Bentué-Ferrer, D; Reymann, JM; Sabouraud, O; Van den Driessche, J | 1 |
Wermuth, L | 1 |
Larsen, JP; Nessler, EG; Strandjord, R | 1 |
Honavar, M; Marsden, CD; Quinn, NP; Ring, H | 1 |
Agniel, A; Celsis, P; Demonet, JF; Marc-Vergnes, JP; Montastruc, JL; Rascol, A; Rascol, O | 1 |
Gollomp, SM; Hurtig, HI; Stern, MB; Vernon, GM | 1 |
Robertson, GS; Robertson, HA | 1 |
Agniel, A; Celsis, P; Demonet, JF; Doyon, B; Marc-Vergnes, JP; Montastruc, JL; Puel, M; Rascol, A | 1 |
Kamphuis, DJ; Lakke, JP; Staal-Schreinemachers, AL; vd Burg, W; Wesseling, H | 1 |
Weil, C | 1 |
Bouchard, S; Gawel, M; Libman, I; Riopelle, R | 1 |
Lindvall, B; Olsson, JE | 1 |
Sandyk, R | 2 |
Gibson, JM; Kennard, C; Pimlott, R | 1 |
Lakke, JP; Staal-Schreinemachers, AL | 1 |
Montastruc, JL; Rascol, A; Schmitt, L; Simonetta, M | 1 |
Riopelle, RJ | 1 |
Bouchard, S | 1 |
de Reuck, J; Tack, E | 1 |
Kadykov, AS; Pivovarova, VM; Shvedkov, VV; Stoliarova, LG | 1 |
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF | 1 |
Demonet, JF; Dueymes, JM; Ioualalen, A; Montastruc, JL; Rascol, A; Rostin, M | 1 |
Klawans, HL; Paleologos, N | 1 |
Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H | 1 |
Draper, IT | 1 |
Wilson, JA | 1 |
D'Alessandro, P; Finali, G; Piccinin, GL; Piccirilli, M; Piccolini, C; Scarcella, MG; Testa, A | 1 |
Calne, DB; Glover, R; Lau, E; Schulzer, M; Waterman, K | 1 |
Johnels, B | 1 |
van der Drift, JH | 1 |
de Pedro, J; Rosenqvist, U | 1 |
Benoit, P; Peutillot, A | 1 |
Jankovic, J | 1 |
Hardie, RJ; Lees, AJ; Stern, GM | 1 |
Bratty, PJ; Burton, K; Calne, DB; Larsen, TA; Martin, WR; Robinson, RG; Schulzer, M | 1 |
Goldstein, M; Lieberman, AN | 1 |
Ito, H; Kameyama, M; Kase, M; Kuroiwa, Y; Mizuno, Y; Nakanishi, T; Narabayashi, H; Sobue, I; Toyokura, Y; Uono, M | 1 |
Feldman, RG; Lannon, MC | 1 |
Dick, DJ; Fletcher, J; Walls, TJ | 1 |
Wirz, D | 1 |
Axelsson, G; Granerus, AK; Noring, L; Tornling, G; Unge, G | 1 |
Schlechte, JA | 1 |
Agid, Y; Dubois, B | 1 |
Elton, RL; Hoehn, MM | 1 |
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G | 1 |
Erkkola, R; Grönroos, M; Liukko, P; Rinne, UK; Salmi, T | 1 |
Delgado, MR; Grimes, JD | 1 |
Kapfhammer, HP; Rüther, E | 1 |
Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N | 1 |
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
Baas, H; Fischer, PA; Japp, G; Schneider, E | 2 |
Glaeske, C; Lorenzo, AS; Pfeiffer, RF; Wilken, K | 1 |
Indo, T | 1 |
Grau-Veciana, JM; Peiró Grasa, A | 1 |
Schott, GD | 1 |
Hershey, LA | 1 |
Brottier, E; Domblides, P; Douvier, JJ; Dubos, F; Freour, P; Taytard, A; Vergeret, J | 1 |
Luquin, MR; Martínez Lage, JM; Obeso, JA | 1 |
Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF | 1 |
86 review(s) available for bromocriptine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus.
Topics: Bromocriptine; Cabergoline; Diabetes Mellitus, Type 2; Dopamine Agonists; Humans; Hyperprolactinemia; Parkinson Disease; Restless Legs Syndrome | 2022 |
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole | 2023 |
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.
Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes | 2017 |
ANNIVERSARY REVIEW: 50 years since the discovery of bromocriptine.
Topics: Acromegaly; Animals; Anniversaries and Special Events; Antiparkinson Agents; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Drug Discovery; Drug Therapy, Combination; Ergotism; History, 20th Century; Hormone Antagonists; Humans; Hyperprolactinemia; Hypoglycemic Agents; Parkinson Disease; Pituitary Neoplasms | 2018 |
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline | 2013 |
Dopaminergic drugs in type 2 diabetes and glucose homeostasis.
Topics: Acromegaly; Animals; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agents; Glucose; Homeostasis; Humans; Parkinson Disease; Polymorphism, Genetic; Prolactinoma; Receptors, Dopamine D2 | 2016 |
Akinetic mutism and parkinsonism after multiple shunt failure: case report and literature review.
Topics: Akinetic Mutism; Antiparkinson Agents; Bromocriptine; Child; Female; Humans; Hydrocephalus; Parkinson Disease; Physical Therapy Modalities; Treatment Outcome; Ventriculoperitoneal Shunt | 2012 |
Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Drug Delivery Systems; Ergolines; Humans; Parkinson Disease; Receptors, Dopamine | 2012 |
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone | 2002 |
DA agonists -- ergot derivatives: pergolide: management of Parkinson's disease.
Topics: Bromocriptine; Dopamine Agonists; Ergot Alkaloids; Humans; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic | 2002 |
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 2002 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease | 2003 |
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone | 2004 |
Ropinirole: current status of the studies.
Topics: Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease | 2004 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Bromocriptine versus levodopa in early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2007 |
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2007 |
Update on antiparkinsonian agents.
Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance | 1982 |
Dopamine and depression: a review of recent evidence. I. Empirical studies.
Topics: Amphetamine; Antipsychotic Agents; Brain; Bromocriptine; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Double-Blind Method; Homovanillic Acid; Humans; Norepinephrine; Parkinson Disease; Piribedil; Receptors, Dopamine; Research | 1983 |
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
Drugs five years later. Bromocriptine.
Topics: Acromegaly; Adenoma; Bromocriptine; Dyskinesia, Drug-Induced; Edema; Female; Growth Hormone; Hepatic Encephalopathy; Humans; Huntington Disease; Infertility, Female; Lactation; Luteal Phase; Male; Mental Disorders; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Premenstrual Syndrome; Prolactin | 1984 |
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis | 1984 |
The pharmacology of Parkinson's disease: basic aspects and recent advances.
Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine | 1984 |
The endocrine profile of bromocriptine: its application in endocrine diseases.
Topics: Bromocriptine; Cushing Syndrome; Endocrine Glands; Growth Hormone; Hormones; Humans; Huntington Disease; Nelson Syndrome; Parkinson Disease; Pituitary Hormones; Prolactin; Thyroxine; Triiodothyronine | 1981 |
Is aldosterone secretion under dopaminergic control?
Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride | 1981 |
The management of Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease | 1982 |
[Stage-adjusted treatment of idiopathic Parkinson syndrome].
Topics: Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Cholinergic Antagonists; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Selegiline | 1995 |
Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages.
Topics: Animals; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Free Radicals; Humans; Levodopa; Mice; Parkinson Disease; Parkinson Disease, Secondary; Premedication; Reactive Oxygen Species; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission | 1994 |
Neuroprotection by dopamine agonists.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Pergolide | 1994 |
[Recent progress of therapy in patients with Parkinson's disease].
Topics: Brain; Bromocriptine; Delayed-Action Preparations; Droxidopa; Drug Resistance; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine | 1993 |
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome | 1993 |
Free radicals and their scavengers in Parkinson's disease.
Topics: Antioxidants; Bromocriptine; Corpus Striatum; Dopamine; Free Radicals; Humans; Lipid Peroxidation; Parkinson Disease; Reactive Oxygen Species; Substantia Nigra | 1993 |
[Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retroperitoneal Fibrosis | 1995 |
Treatment of early Parkinson's disease: are complicated strategies justified?
Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline | 1996 |
Drug management of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl | 1996 |
New directions in the drug treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline | 1996 |
[Treatment of Parkinson's disease with multiple drugs].
Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide | 1997 |
Newer therapies for Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Parkinson Disease | 1996 |
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic | 1998 |
Pregnancy in Parkinson's disease: a review of the literature and a case report.
Topics: Adult; Antiparkinson Agents; Bromocriptine; Female; Humans; Infant, Newborn; Male; Parkinson Disease; Pregnancy; Pregnancy Complications | 1999 |
Dopamine agonists.
Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome | 1999 |
The initial treatment of Parkinson's disease should begin with levodopa.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors | 1999 |
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome | 2000 |
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide | 2000 |
Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 2000 |
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease | 2000 |
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2000 |
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles | 2000 |
Bromocriptine versus levodopa in early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2000 |
[The new Parkinson's disease drugs].
Topics: Antiparkinson Agents; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease | 2000 |
[Parkinson disease: diagnostic and therapeutic criteria].
Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus | 2001 |
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2001 |
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2001 |
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles | 2001 |
[Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Male; Parkinson Disease; Pleuropneumonia; Pulmonary Fibrosis; Tomography, X-Ray Computed | 1998 |
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 2002 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
Bromocriptine in the treatment of parkinsonism.
Topics: Apomorphine; Bromocriptine; Catecholamines; Drug Interactions; Ergolines; Humans; Kinetics; Motor Activity; Movement Disorders; Parkinson Disease; Piribedil; Receptors, Drug; Stereotyped Behavior | 1979 |
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor | 1979 |
Bromocriptine.
Topics: Acromegaly; Animals; Behavior, Animal; Biogenic Amines; Bromocriptine; Central Nervous System; Dopamine; Emetics; Female; Galactorrhea; Growth Hormone; Hallucinations; Hemodynamics; Hormones; Humans; Kinetics; Norepinephrine; Parkinson Disease; Pregnancy; Prolactin; Receptors, Dopamine; Serotonin | 1977 |
Bromocriptine in Parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced | 1978 |
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine | 1979 |
Drug therapy: Bromocriptine.
Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1979 |
[Psychiatric manifestations induced by dopamine precursors or antagonists].
Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride | 1979 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Dopamine Agents; Humans; Lactose; Lisuride; Methylcellulose; Oxazines; Parkinson Disease; Pergolide; Receptors, Dopamine | 1992 |
Drug therapy of Parkinson's disease. An overview.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 1992 |
[Current therapeutic approach in Parkinson disease].
Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E | 1992 |
[New anti-parkinsonian drugs].
Topics: Antiparkinson Agents; Bromocriptine; Humans; Lisuride; Parkinson Disease; Pergolide; Picolinic Acids; Selegiline | 1991 |
Dopaminergic agonists in the treatment of Parkinson's disease.
Topics: Bromocriptine; Dopamine Agents; Humans; Parkinson Disease; Pergolide | 1990 |
Retroperitoneal fibrosis in two patients with Parkinson's disease treated with bromocriptine.
Topics: Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis | 1990 |
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception | 1986 |
[Parkinson disease. The clinical picture and therapy].
Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease | 1988 |
Receptor changes during chronic dopaminergic stimulation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome | 1988 |
New perspectives in the treatment of Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Selegiline; Sincalide | 1986 |
'On-off' phenomenon: description, incidence and management.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Selegiline | 1987 |
Controversies in the management of Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Selegiline | 1986 |
Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Topics: Antiparkinson Agents; Bromocriptine; Dopamine; Ergolines; Humans; Parkinson Disease; Piperazines | 1987 |
The safety of bromocriptine in long-term use: a review of the literature.
Topics: Acromegaly; Adenoma; Bromocriptine; Female; Fetus; Humans; Male; Parkinson Disease; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Time Factors | 1986 |
Long-term use of dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors | 1985 |
The controversial role of bromocriptine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Time Factors | 1985 |
Bromocriptine in Parkinson disease.
Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1985 |
Update on the treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors | 1985 |
139 trial(s) available for bromocriptine and Idiopathic Parkinson Disease
Article | Year |
---|---|
[Efficacy and safety of ropinirole in the treatment of Parkinson's disease: a multi-center, randomized, double-blind and bromocriptine-controlled trial].
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease | 2013 |
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Quality of Life; Selegiline | 2008 |
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult | 2009 |
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Rheology; Severity of Illness Index; Statistics, Nonparametric; Urinary Bladder Diseases; Urodynamics | 2009 |
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Withholding Treatment | 2002 |
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome | 2003 |
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Piribedil; Psychomotor Agitation; Severity of Illness Index; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2003 |
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Thiazoles; Time Factors; Treatment Outcome | 2003 |
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cabergoline; Ergolines; Humans; Parkinson Disease; Pergolide; Prospective Studies; Treatment Outcome | 2004 |
The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Case-Control Studies; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Piribedil; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1982 |
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis | 1984 |
Lisuride treatment in Parkinson's disease: clinical and pharmacokinetic studies.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
Comparison of pergolide and bromocriptine therapy in parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
Topics: Aged; Benserazide; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Random Allocation; Time Factors | 1984 |
Low-dose bromocriptine therapy in severe Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors | 1984 |
Pergolide in late-stage Parkinson disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders | 1982 |
Bromocriptine (ParlodelR) in the treatment of Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic | 1982 |
[Bromocriptine in the treatment of Parkinson's disease].
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease | 1982 |
[Bromocriptin in the treatment of progressive stages of Parkinson's disease (author's transl)].
Topics: Aged; Bromocriptine; Dihydroxyphenylalanine; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Placebos | 1982 |
Prolactin secretion in Parkinson disease.
Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1981 |
Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors | 1980 |
Assessment of hypokinesia in Parkinsonism.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors | 1981 |
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
Topics: Bromocriptine; Carbidopa; Clinical Trials as Topic; Follow-Up Studies; Humans; Levodopa; Parkinson Disease | 1981 |
The effect of bromocriptine (BCT) on the on-off phenomenon.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease | 1981 |
Weekly drug holiday in Parkinson disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Ergolines; Female; Humans; Lisuride; Male; Middle Aged; Parkinson Disease; Random Allocation | 1982 |
Bromocriptine and domperidone in the treatment of Parkinson disease.
Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting | 1981 |
Bromocriptine: low-dose therapy in Parkinson disease.
Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor | 1982 |
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome | 1995 |
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome | 1994 |
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease | 1994 |
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure | 1994 |
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
Topics: Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies | 1994 |
Visual control of arm movement in Parkinson's disease.
Topics: Adult; Aged; Attention; Benserazide; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline | 1994 |
Progress note on Japanese multicenter bromocriptine monotherapy.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease | 1993 |
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Selegiline; Treatment Outcome | 1993 |
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1993 |
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors | 1993 |
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor | 1995 |
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide | 1995 |
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Cause of Death; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Selegiline; Time Factors; Treatment Failure | 1995 |
L-deprenyl as an adjunct to low-dose bromocriptine in early Parkinson's disease: a short-term, double-blind, and prospective follow-up study.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Chemotherapy, Adjuvant; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Parkinson Disease; Placebos; Prospective Studies; Selegiline | 1995 |
Bromocriptine therapy in early-stage Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disease Progression; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Time Factors; Treatment Outcome | 1996 |
The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Predictive Value of Tests; Prognosis; Regression Analysis; Sensitivity and Specificity | 1995 |
Age at onset: the major determinant of outcome in Parkinson's disease.
Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor | 1995 |
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease | 1996 |
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Cabergoline; Double-Blind Method; Ergolines; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1996 |
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Parkinson Disease; Prospective Studies; Time Factors | 1996 |
Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Placebos; Prospective Studies | 1997 |
Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1997 |
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone | 1997 |
Discontinuation of prolonged bromocriptine therapy in Parkinson's disease patients with uncontrolled motor oscillations.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies | 1994 |
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome | 1997 |
Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1997 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index | 1997 |
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Confidence Intervals; Disease Progression; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indoles; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Parkinson Disease; Regression Analysis; Selegiline; Severity of Illness Index; Treatment Outcome | 1998 |
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry
Topics: Antiparkinson Agents; Bromocriptine; Cause of Death; Disabled Persons; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Proportional Hazards Models; Selegiline; Survival Rate; Treatment Failure | 1998 |
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome | 1997 |
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome | 1999 |
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1999 |
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome | 2000 |
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
Topics: Aged; Blood Pressure; Bromocriptine; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline | 2000 |
Long-term persistence of symptomatic effect of selegiline in Parkinson's disease. A two-months placebo-controlled withdrawal study.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Selegiline; Severity of Illness Index; Single-Blind Method; Substance Withdrawal Syndrome | 2001 |
Suppressed sympathetic skin response in Parkinson disease.
Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Electric Stimulation; Evoked Potentials; Evoked Potentials, Auditory; Female; Foot; Hand; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Reference Values; Selegiline; Skin; Sympathetic Nervous System | 2000 |
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Levodopa; Male; Middle Aged; Mortality; Parkinson Disease; Prospective Studies; Treatment Outcome | 2001 |
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial.
Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Disability Evaluation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Parkinson Disease; Selegiline; Treatment Outcome | 2001 |
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease | 2002 |
Ropinirole for the treatment of tremor in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor | 2002 |
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Treatment Outcome | 2002 |
Editorial: Bromocriptine.
Topics: Acromegaly; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy | 1975 |
Letter: Bromocriptine in parkinsonism.
Topics: Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Parkinson Disease | 1975 |
Letter: Bromocriptine in parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease | 1975 |
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1976 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl | 1978 |
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Benzimidazoles; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dopamine Antagonists; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Piperidines; Placebos; Receptors, Dopamine | 1979 |
Lisuride in Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Ergolines; Humans; Lisuride; Parkinson Disease | 1979 |
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonism.
Topics: Bromocriptine; Caffeine; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease; Phosphodiesterase Inhibitors | 1976 |
An ergot derivative in the treatment of Parkinson's disease.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease | 1976 |
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease | 1977 |
Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1977 |
Bromocriptine in the treatment of advanced Parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1977 |
Treatment of Parkinson's disease with lergotrile mesylate.
Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease | 1977 |
Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Placebos; Psychiatric Status Rating Scales | 1978 |
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1978 |
Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
Topics: Aged; Blood Pressure; Bromocriptine; Clinical Trials as Topic; Female; Growth Hormone; Humans; Male; Metoclopramide; Middle Aged; Nausea; Parkinson Disease; Time Factors; Vomiting | 1978 |
Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Syndrome | 1978 |
A double-blind trial of bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
An evaluation of bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 1978 |
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1976 |
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor | 1976 |
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl | 1976 |
Dopaminergic agonists in Parkinsonism.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos | 1975 |
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease | 1992 |
Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.
Topics: Benserazide; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease; Prospective Studies; Psychomotor Performance | 1992 |
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment.
Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report.
Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies | 1992 |
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
Topics: Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Performance | 1992 |
Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception | 1992 |
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO.
Topics: Administration, Oral; Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1992 |
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1 | 1992 |
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.
Topics: Adult; Aged; Aged, 80 and over; Behavior; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease | 1991 |
A multi-center, double-blind study on slow-release bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Humans; Middle Aged; Parkinson Disease | 1991 |
Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease.
Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
Randomized double-blind trial of injectable heptaminol for controlling spontaneous or bromocriptine-induced orthostatic hypotension in parkinsonians.
Topics: Blood Pressure; Bromocriptine; Double-Blind Method; Female; Heart Rate; Heptaminol; Humans; Hypotension, Orthostatic; Injections, Intravenous; Male; Middle Aged; Parkinson Disease; Renin | 1990 |
Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Japan; Levodopa; Middle Aged; Multicenter Studies as Topic; Parkinson Disease | 1990 |
Bromocriptine as initial therapy in elderly parkinsonian patients. The Bromocriptine Multicentre Trial Group.
Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Parkinson Disease | 1990 |
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic | 1990 |
Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease | 1990 |
Adjunctive therapy with bromocriptine in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1990 |
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline | 1989 |
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1989 |
Bromocriptine in Parkinson's disease: a double-blind study comparing "low-slow" and "high-fast" introductory dosage regimens in de novo patients. UK Bromocriptine Research Group.
Topics: Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation | 1989 |
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation | 1989 |
The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease | 1989 |
Long term bromocriptine treatment in de novo parkinsonian patients.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1988 |
[Parlodel: a new therapeutic possibility in the management of Parkinson disease].
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hungary; Male; Middle Aged; Parkinson Disease | 1988 |
A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Parkinson Disease; Random Allocation | 1988 |
A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease; Prospective Studies | 1988 |
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapy.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1988 |
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease | 1987 |
Low-dose bromocriptine in the early phases of Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors | 1987 |
A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies | 1988 |
Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Random Allocation; Tremor | 1986 |
Patients sought for New Zealand multi-centre Parkinson's disease trial.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; New Zealand; Parkinson Disease | 1987 |
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation | 1987 |
Treatment of early morning akinesia with low-dose bromocriptine.
Topics: Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1987 |
The Sydney multicentre study of Parkinson's disease. The first 18 months.
Topics: Australia; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Levodopa; Parkinson Disease | 1987 |
Bromocriptine and the clinical spectrum of Parkinson's disease.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1987 |
Parkinson's disease: a comparison of mesulergine and bromocriptine.
Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Female; Humans; Male; Middle Aged; Movement; Nervous System; Parkinson Disease | 1985 |
Effects of bromocriptine on parkinsonism. A nation-wide collaborative double-blind study.
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary | 1985 |
Low dosages of bromocriptine added to levodopa in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1985 |
Low-dose bromocriptine therapy in Parkinson's disease.
Topics: Aged; Bromocriptine; Humans; Middle Aged; Parkinson Disease | 1985 |
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
388 other study(ies) available for bromocriptine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Troponoids. 6. Troponylpiperazines: a new class of dopamine agonists.
Topics: Animals; Bromocriptine; Cycloheptanes; Disease Models, Animal; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Piperazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Structure-Activity Relationship; Tropolone | 1984 |
Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease.
Topics: Animals; Antioxidants; Bromocriptine; Catalase; Emulsions; Glutathione; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2022 |
CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect.
Topics: Animals; Behavior, Animal; Bromocriptine; Cell Line, Tumor; Cell Survival; Drug Development; Emulsions; Glutathione; Goats; Humans; Hydrogen-Ion Concentration; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Particle Size; Rats; Rats, Wistar | 2021 |
Multiple valvular regurgitation associated with bromocriptine therapy.
Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Echocardiography, Doppler, Color; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease | 2014 |
An exploratory evaluation of tyrosine hydroxylase inhibition in planaria as a model for parkinsonism.
Topics: Animals; Bromocriptine; Humans; Light; Locomotion; Models, Animal; Monoiodotyrosine; Parkinson Disease; Planarians; Protein Binding; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 2013 |
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture | 2013 |
Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Biological Availability; Biological Transport; Blood-Brain Barrier; Brain; Bromocriptine; Chitosan; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Drug Delivery Systems; Female; Male; Mass Spectrometry; Mice; Nanoparticles; Nasal Mucosa; Parkinson Disease; Radiopharmaceuticals; Sodium Pertechnetate Tc 99m; Tissue Distribution | 2014 |
Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease.
Topics: Alginates; Animals; Animals, Genetically Modified; Brain; Bromocriptine; Crosses, Genetic; Disease Models, Animal; Dose-Response Relationship, Drug; Drosophila melanogaster; Female; Glutathione; Glutathione Transferase; Lipid Peroxidation; Male; Nanocomposites; Parkinson Disease; Permeability; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2016 |
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.
Topics: Animals; Antiparkinson Agents; Biosensing Techniques; Bromocriptine; Catecholamines; Dopamine Agonists; Dopaminergic Neurons; Equipment Design; Levodopa; Mice; Molecular Imaging; Nanotechnology; Neuroimaging; Parkinson Disease; Precision Medicine; Substantia Nigra | 2017 |
Bromocriptine use and the risk of valvular heart disease.
Topics: Aged; Aortic Valve Insufficiency; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Echocardiography, Doppler; Female; Heart Valve Diseases; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Receptor, Serotonin, 5-HT2B; Risk Factors; Severity of Illness Index; Tricuspid Valve Insufficiency | 2009 |
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors | 2009 |
Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Topics: Animals; Antioxidants; Biopterins; Bromocriptine; Cell Death; Cell Line; Cytochromes c; Dopamine; Dopamine Agonists; Enzymes; L-Lactate Dehydrogenase; Mice; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Receptors, Dopamine; Signal Transduction; Up-Regulation | 2009 |
Dopamine agonists, Dopplers and doubt: cabergoline-associated cardiac valvulopathy.
Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Male; Parkinson Disease; Pergolide; Prolactin; Serotonin 5-HT2 Receptor Agonists; Ultrasonography | 2009 |
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.
Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome | 2009 |
Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Blood-Brain Barrier; Blotting, Western; Brain; Bromocriptine; Disease Models, Animal; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease; Tissue Distribution | 2009 |
[General anaesthesia for neurological diseases].
Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome | 2010 |
The history of ergot of rye (Claviceps purpurea) III: 1940-80.
Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale | 2010 |
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis | 2011 |
Bromocriptine use and myocardial function.
Topics: Bromocriptine; Dopamine Agonists; Echocardiography; Follow-Up Studies; Heart; Humans; Myocardial Infarction; Parkinson Disease; Ultrasonography | 2011 |
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies | 2011 |
Bromocriptine and dopamine receptor stimulation.
Topics: Aged; Blood Pressure; Bromocriptine; Dopamine Agonists; Female; Human Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1976 |
Some consequences of assuming simple patterns for the treatment effect over time in a linear mixed model.
Topics: Activities of Daily Living; Antiparkinson Agents; Biostatistics; Bromocriptine; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Indoles; Linear Models; Models, Statistical; Parkinson Disease; Randomized Controlled Trials as Topic | 2013 |
Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Topics: Administration, Intranasal; Animals; Antiparkinson Agents; Behavior, Animal; Blood-Brain Barrier; Brain; Bromocriptine; Catalepsy; Chitosan; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Hypokinesia; Injections, Intravenous; Male; Mice; Nanoparticles; Neurons; Parkinson Disease; Radionuclide Imaging; Random Allocation; Sodium Pertechnetate Tc 99m; Tissue Distribution | 2013 |
Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide.
Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Pergolide | 2002 |
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease | 2003 |
The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
Topics: Adult; Aged; Antiparkinson Agents; British Columbia; Bromocriptine; Data Interpretation, Statistical; Databases, Factual; Drug Prescriptions; Drug Utilization; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors | 2003 |
[Sexual delinquency and Parkinson's disease].
Topics: Antiparkinson Agents; Awareness; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exhibitionism; Expert Testimony; Humans; Impulsive Behavior; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pedophilia; Sex Offenses | 2003 |
Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.
Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Neostriatum; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D2; Rotation; Substantia Nigra | 2003 |
[Therapy for patients with early-stage Parkinson's disease].
Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl | 2003 |
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness | 2004 |
Effects of pergolide on nocturia in Parkinson's disease: three female cases selected from over 400 patients.
Topics: Aged; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Patient Selection; Pergolide; Urination Disorders | 2004 |
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception | 2004 |
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles | 2004 |
Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.
Topics: Aortic Valve; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Fibrosis; Heart Valve Diseases; Humans; Parkinson Disease; Pergolide | 2004 |
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors | 2005 |
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.
Topics: Bromocriptine; Cross-Sectional Studies; Disease Progression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2005 |
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2005 |
Bromocriptine treatment in a murine Parkinson's model: ultrastructural evaluation after dopaminergic deafferentation.
Topics: Animals; Antiparkinson Agents; Bromocriptine; Caudate Nucleus; Disease Models, Animal; Dopamine; Male; Motor Endplate; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar | 2005 |
Bromocriptine in traumatic brain injury.
Topics: Brain Injuries; Bromocriptine; Cognition; Dopamine Agonists; Head Injuries, Closed; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance | 2006 |
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis | 2006 |
Tolcapone: new drug. In Parkinson's disease: unacceptable risk of severe hepatitis.
Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Clinical Trials as Topic; Cost-Benefit Analysis; Dopamine Agonists; Hepatitis; Humans; Nitrophenols; Parkinson Disease; Treatment Outcome | 2006 |
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome | 2006 |
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Dopamine Agonists; Echocardiography; Ergot Alkaloids; Heart Valve Diseases; Humans; Middle Aged; Parkinson Disease; Pergolide; Reference Values | 2006 |
Changes in gait and symptoms after bilateral pallidotomy: a client with Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Disease Progression; Female; Gait; Globus Pallidus; Humans; Levodopa; Middle Aged; Pallidotomy; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
Topics: Animals; Bromocriptine; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Line; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Quinpirole | 2007 |
Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine.
Topics: Adolescent; Antiparkinson Agents; Bromocriptine; Catechols; Drug Therapy, Combination; Epilepsy; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pregnancy; Prenatal Exposure Delayed Effects | 2007 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage.
Topics: Active Transport, Cell Nucleus; Animals; Antiparkinson Agents; Bromocriptine; Cytoprotection; Dopamine Agonists; Hydrogen Peroxide; NAD(P)H Dehydrogenase (Quinone); Neurons; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Receptors, Dopamine D2; Signal Transduction; Up-Regulation | 2008 |
Dopamine agonists and Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine | 1984 |
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Topics: Aged; Bromocriptine; Cognition Disorders; Confusion; Dose-Response Relationship, Drug; Electroencephalography; Ergolines; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Personality Disorders; Psychoses, Substance-Induced; Schizophrenia | 1980 |
Progress in the pharmacotherapy of Parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Dopamine Antagonists; Ergolines; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine | 1980 |
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.
Topics: Bromocriptine; Dyspnea; Humans; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Time Factors | 1981 |
Pleuropulmonary shadows on bromocriptine.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Lung; Male; Middle Aged; Parkinson Disease; Pleura; Radiography | 1981 |
Bromocriptine for levodopa-induced end-of-dose dystonia.
Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease | 1981 |
[Bromocriptine therapy].
Topics: Acromegaly; Bromocriptine; Female; Humans; Lactation; Neurotransmitter Agents; Parkinson Disease; Pregnancy; Prolactin | 1981 |
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay | 1982 |
Bromocriptine induced collagenosis-like symptomatology in Parkinson's disease.
Topics: Bromocriptine; Collagen Diseases; Female; Humans; Middle Aged; Parkinson Disease | 1982 |
[Drug therapy of parkinsonism].
Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease | 1982 |
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
Topics: Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Ergolines; Female; Hydroxydopamines; Oxidopamine; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains | 1982 |
[How do we explain the antihypertensive effect of bromocriptine? Clinical and experimental contribution].
Topics: Adrenergic alpha-Antagonists; Aged; Animals; Antihypertensive Agents; Bromocriptine; Dogs; Domperidone; Drug Therapy, Combination; Epinephrine; Female; Humans; Hypertension; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1984 |
Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1982 |
[Therapeutic concept in Parkinson disease].
Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor | 1983 |
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease | 1983 |
Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.
Topics: Aged; Bromocriptine; Drug Eruptions; Erythromelalgia; Female; Humans; Male; Middle Aged; Parkinson Disease | 1981 |
Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison.
Topics: Adult; Aged; Bromocriptine; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Parkinson Disease | 1983 |
Dopamine agonists in Parkinson's disease.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1984 |
[Treatment of Parkinson's disease with high doses of bromocriptine. Possible interaction with josamycin].
Topics: Aged; Bromocriptine; Drug Interactions; Humans; Leucomycins; Male; Parkinson Disease | 1984 |
Dopamine agonists in the treatment of Parkinson's disease.
Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors | 1983 |
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
Topics: Apomorphine; Brain; Bromocriptine; Humans; Levodopa; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Opioid; Thyrotropin-Releasing Hormone | 1983 |
Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.
Topics: Acromegaly; Bromocriptine; Calcitriol; Danazol; Endometriosis; Etidronic Acid; Female; Fibrocystic Breast Disease; Humans; Hydroxycholecalciferols; Hypoparathyroidism; Kidney Failure, Chronic; Lactation; Menorrhagia; Osteomalacia; Parkinson Disease; Pregnadienes; Pregnancy; Prolactin; Rickets; Vitamin D | 1983 |
Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Lisuride; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tranylcypromine | 1983 |
[Dopaminergic ergot combinations. A new therapeutic principle].
Topics: Bromocriptine; Dopamine Antagonists; Drug Combinations; Ergot Alkaloids; Female; Humans; Lisuride; Male; Parkinson Disease; Pituitary Neoplasms; Prolactin | 1983 |
Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
Topics: Benzamides; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Phenethylamines; Selegiline; Tiapamil Hydrochloride | 1984 |
Therapy of neurologic disorders in the elderly.
Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl | 1984 |
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1984 |
Bromocriptine update.
Topics: Acromegaly; Bromocriptine; Female; Humans; Hypotension, Orthostatic; Lactation; Male; Nausea; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin | 1984 |
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease | 1984 |
Bromocriptine in the management of end of dose deterioration in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease | 1984 |
Pergolide versus bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pergolide | 1984 |
Severity of Parkinson's disease and the dosage of bromocriptine.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies | 1984 |
[Does bromocriptine enhance the effect of drugs that reduce intraocular pressure?].
Topics: Bromocriptine; Drug Synergism; Humans; Intraocular Pressure; Parkinson Disease | 1983 |
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine | 1983 |
Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
Topics: Benserazide; Bromocriptine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunction, Physiological | 1983 |
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Bromocriptine and lisuride in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1984 |
Clinical administration of parlodel in low doses.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1984 |
Bromocriptine in Parkinson's disease: results obtained with high and low dose therapy.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Parkinson Disease | 1984 |
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1984 |
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine.
Topics: Aged; Bromocriptine; Drug Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease; Retrospective Studies; Time Factors | 1984 |
Diagnosis and management of Parkinson's disease.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor | 1984 |
Long-term efficacy of bromocriptine in Parkinson disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome | 1980 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Incontinence of urine with long-term bromocriptine therapy.
Topics: Bromocriptine; Humans; Long-Term Care; Male; Middle Aged; Parkinson Disease; Urinary Incontinence | 1980 |
The use of bromocriptine for testing central dopaminergic reactivity.
Topics: Blood Pressure; Brain; Bromocriptine; Drug Resistance; Humans; Levodopa; Movement Disorders; Parkinson Disease; Receptors, Dopamine; Renin | 1980 |
Bromocriptine and lisuride in Parkinson disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1983 |
Progressive supranuclear palsy: clinical features and response to treatment in 16 patients.
Topics: Aged; Bromocriptine; Bulbar Palsy, Progressive; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Pergolide | 1983 |
Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
Topics: Bromocriptine; Disability Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Time Factors | 1983 |
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1983 |
Dopa dose-dependent sexual deviation.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Humans; Male; Middle Aged; Paraphilic Disorders; Parkinson Disease; Pergolide | 1983 |
Bromocriptine in the long-term management of advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Evaluation; Follow-Up Studies; Humans; Parkinson Disease; Time Factors | 1983 |
Bromocriptine--lisuride cross tolerance.
Topics: Aged; Bromocriptine; Drug Tolerance; Ergolines; Humans; Lisuride; Male; Middle Aged; Parkinson Disease | 1983 |
[Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
Topics: Bromocriptine; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1983 |
Bromocriptine and endocrine imbalance.
Topics: Bromocriptine; Humans; Parkinson Disease; Pituitary Hormones | 1981 |
Recent advances in the treatment of Parkinson's disease.
Topics: Brain; Bromocriptine; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine | 1980 |
[Sleep-waking cycle and the nyctohemeral secretion of prolactin and somatotropin in Parkinson patients. Effect of bromocriptine].
Topics: Bromocriptine; Circadian Rhythm; Female; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Prolactin; Sleep | 1980 |
[Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)].
Topics: Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Humans; Parkinson Disease; Receptors, Dopamine | 1982 |
[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
Topics: Adult; Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1982 |
Initial treatment of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis | 1982 |
Behavioral alterations and the therapy of parkinsonism.
Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced | 1982 |
Bromocriptine combined with levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease | 1982 |
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1982 |
[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease | 1982 |
[Bromocriptine - various pharmacological properties and indications for use].
Topics: Acromegaly; Bromocriptine; Female; Galactorrhea; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin | 1982 |
Bromocriptine.
Topics: Acromegaly; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Lactation; Male; Parkinson Disease; Pregnancy; Prolactin | 1980 |
Galactorrhoea after withdrawal of bromocriptine.
Topics: Adult; Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy; Prolactin; Substance Withdrawal Syndrome | 1980 |
Lisuride in parkinsonism.
Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Ergolines; Humans; Lisuride; Middle Aged; Movement; Parkinson Disease; Placebos; Reaction Time; Receptors, Serotonin; Sleep | 1981 |
Bilateral vocal cord paralysis in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tracheotomy; Vocal Cord Paralysis | 1981 |
[Treatment of Parkinson disease by bromocriptine in the black African].
Topics: Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Senegal | 1980 |
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
Method of addition of bromocriptine to the drug regime of patients with advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines | 1981 |
Parkinson's disease: new treatments.
Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus | 1981 |
Bromocriptine and its use in Parkinsonism.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease | 1981 |
Treatment of Parkinson's disease: problems with a progressing disease.
Topics: Bromocriptine; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Prognosis; Receptors, Dopamine | 1981 |
Bromocriptine in Parkinson's disease: a study of cardiovascular effects.
Topics: Benzimidazoles; Blood Pressure; Bromocriptine; Domperidone; Humans; Parkinson Disease; Piperidines; Pulse | 1981 |
[Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases | 1981 |
Bromocriptine.
Topics: Breast Diseases; Bromocriptine; Female; Humans; Lactation; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin | 1981 |
"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic | 1981 |
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1981 |
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Further experiences with low doses of bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease | 1980 |
Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
The role of bromocriptine in the treatment of Parkinson's disease.
Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
A comparative study of bromocriptine and levodopa in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1980 |
The role of D-1 and D-2 receptors.
Topics: Adenylyl Cyclases; Bromocriptine; Growth Hormone; Humans; Levodopa; Lisuride; Metoclopramide; Parkinson Disease; Pimozide; Prolactin; Receptors, Dopamine | 1980 |
Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease.
Topics: Aged; Blood Proteins; Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Protein Binding; Saliva; Time Factors | 1980 |
Lisuride in the treatment of Parkinsonism.
Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease | 1980 |
Neuroprotective mechanism of bromocriptine.
Topics: Amino Acid Transport System X-AG; Antiparkinson Agents; ATP-Binding Cassette Transporters; Biological Transport; Bromocriptine; Carrier Proteins; Dopamine Agonists; Glutamic Acid; HeLa Cells; Humans; Neuroprotective Agents; Parkinson Disease | 1995 |
Treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline | 1995 |
Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study.
Topics: Administration, Oral; Aged; Benserazide; Bromocriptine; Deglutition; Deglutition Disorders; Drug Administration Schedule; Eating; Humans; Levodopa; Male; Parkinson Disease | 1995 |
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome | 1995 |
Bromocriptine and psychosis: a literature review.
Topics: Amenorrhea; Bromocriptine; Female; Humans; Parkinson Disease; Psychotic Disorders; Puerperal Disorders | 1995 |
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 1994 |
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating | 1995 |
Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Neurons; Parkinson Disease; Substantia Nigra | 1994 |
Day-night variation of urine volume in Parkinson's disease.
Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine | 1994 |
On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cocaine; Dopamine Agents; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 1993 |
[Bromocriptine-induced pleuropneumopathy].
Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors | 1994 |
[Diagnosis and treatment of Parkinson's disease in the elderly].
Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride | 1993 |
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1994 |
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception | 1993 |
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication.
Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis | 1993 |
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM | 1993 |
Combination therapy for PD.
Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Randomized Controlled Trials as Topic | 1993 |
Combination therapy for PD.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic | 1993 |
Event-related potentials in Parkinson's disease: a 12-month follow-up study.
Topics: Adult; Aged; Bromocriptine; Cognition; Drug Therapy, Combination; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies | 1993 |
Parkinson's disease study.
Topics: Benserazide; Bias; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1993 |
Amantadine withdrawal and neuroleptic malignant syndrome.
Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 1993 |
Function of dopamine receptors in young-onset Parkinson's disease: prolactin response.
Topics: Adult; Bromocriptine; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Dopamine D2; Thyrotropin-Releasing Hormone | 1993 |
Neuroprotection in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Humans; Neuroprotective Agents; Parkinson Disease | 1996 |
Suggestive evidence for bromocriptine-induced pleurisy.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Humans; Male; Parkinson Disease; Pleurisy; Radiography | 1996 |
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Dominance, Cerebral; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Thalamic Nuclei; Treatment Outcome | 1996 |
Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbolines; Female; Humans; Levodopa; Male; Middle Aged; Mitochondria; Parkinson Disease; Selegiline | 1995 |
[Malignant-like neuroleptic syndrome: a sign to call attention to].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease | 1995 |
Analyzer workshop on the treatment of Parkinson's disease.
Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets | 1997 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor | 1997 |
Prevalence of orthostatic hypotension in Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Prevalence; Severity of Illness Index | 1997 |
[Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
Topics: Aged; Anti-Bacterial Agents; Antiparkinson Agents; Bromocriptine; Drug Interactions; Erythromycin; Female; Humans; Parkinson Disease; Psychoses, Substance-Induced | 1997 |
Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
Topics: Adolescent; Adult; Aged; Antiparkinson Agents; Asbestos; Bromocriptine; Bronchoalveolar Lavage; Cohort Studies; Environmental Monitoring; Epidemiological Monitoring; Follow-Up Studies; Humans; Middle Aged; Occupational Exposure; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis; Radiography; Respiratory Function Tests; Risk Factors | 1997 |
Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
Topics: Antiparkinson Agents; Asbestosis; Bromocriptine; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pleural Effusion; Pulmonary Fibrosis; Tomography, X-Ray Computed | 1997 |
Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early.
Topics: Antiparkinson Agents; Bromocriptine; Decision Making; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline | 1998 |
Ropinirole: new preparation. Wait for more convincing data.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; France; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Time Factors; Treatment Outcome | 1998 |
[A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Topics: Anticoagulants; Antiparkinson Agents; Bromocriptine; Dantrolene; Disseminated Intravascular Coagulation; Female; Gabexate; Humans; Middle Aged; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Parkinson Disease; Status Epilepticus | 1999 |
Chronic constrictive pericarditis induced by long-term bromocriptine therapy: report of two cases.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Chronic Disease; Dyspnea; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Time Factors | 1999 |
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors | 1999 |
An overnight switch to ropinirole therapy in patients with Parkinson's disease. Short communication.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Therapeutic Equivalency | 1999 |
Repeated co-administration of caffeine and bromocriptine prevents tolerance to the effects of caffeine in the turning behavior animal model.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Drug Therapy, Combination; Drug Tolerance; Male; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Rats | 1999 |
Sleep attacks and Parkinson's disease treatment.
Topics: Accidents, Traffic; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Narcolepsy; Parkinson Disease; Pergolide; Piribedil | 2000 |
[A pleurisy that can speak of her].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Parkinson Disease; Pleurisy | 2000 |
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2000 |
[Dopaminergic agonists in the treatment of Parkinson's disease].
Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles | 2000 |
Neuroleptic malignant syndrome without neuroleptics.
Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome | 2001 |
Pergolide and Parkinson's disease: new preparation. No clear benefit.
Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome | 2000 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation.
Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2001 |
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.
Topics: Aged; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Hospitalization; Humans; Japan; Male; Markov Chains; Middle Aged; Parkinson Disease; Pergolide; Quality-Adjusted Life Years | 2001 |
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins | 2002 |
Update on drug treatment of Parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1977 |
Dopaminephilic properties of ergot alkaloids.
Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase | 1978 |
Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Confusion; Depression; Ergolines; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Schizophrenia, Paranoid | 1978 |
Ergot derivatives for Parkinsonism.
Topics: Bromocriptine; Ergolines; Humans; Parkinson Disease; Pyridines | 1978 |
Lergotrile in Parkinson disease: further studies.
Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease | 1979 |
Letter: Growth-hormone response to bromocriptine in parkinsonism.
Topics: Bromocriptine; Ergolines; Growth Hormone; Humans; Parkinson Disease | 1976 |
Letter: Growth-hormone responses in Parkinson's disease.
Topics: Bromocriptine; Growth Hormone; Humans; Levodopa; Parkinson Disease | 1976 |
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid | 1976 |
Digital vasospasm with bromocriptine.
Topics: Aged; Blood Vessels; Bromocriptine; Constriction, Pathologic; Female; Fingers; Humans; Middle Aged; Parkinson Disease | 1976 |
Bromocriptine in parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Humans; Parkinson Disease | 1976 |
Long-term treatment of parkinsonism with bromocriptine.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Time Factors | 1978 |
Drugs for Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines | 1978 |
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.
Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Sleep | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
Endocrine aspects of bromocriptine therapy in Parkinsonism.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Growth Hormone; Humans; Long-Term Care; Middle Aged; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1978 |
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline | 1979 |
Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Topics: Bromocriptine; Ergolines; Growth Hormone; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Parkinson Disease; Prolactin | 1976 |
[Neurology in 1977].
Topics: Bromocriptine; Defense Mechanisms; Dopamine; Facial Paralysis; gamma-Aminobutyric Acid; Hemiplegia; Humans; Huntington Disease; Nervous System Diseases; Ophthalmoplegia; Parkinson Disease; Prognosis; Serotonin | 1977 |
Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
Topics: Animals; Bromocriptine; Cyclic AMP; Ergolines; Female; Humans; Huntington Disease; Male; Middle Aged; Motor Activity; Nervous System Diseases; Parkinson Disease; Rats; Schizophrenia; Stereotyped Behavior; Synapses | 1977 |
In practice. Parkinson's disease.
Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission | 1979 |
Bromocriptine and parkinsonism.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1978 |
Bromocriptine mesylate in Parkinson's disease.
Topics: Bromocriptine; Edema; Humans; Mental Disorders; Middle Aged; Parkinson Disease | 1979 |
[Experimental and clinical study on the dopaminergic receptor stimulating agents (author's transl)].
Topics: Adult; Aged; Animals; Bromocriptine; Dopamine; Female; Haplorhini; Humans; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Receptors, Dopamine; Tremor | 1977 |
Parkinson's disease: search for better therapies.
Topics: Bromocriptine; Humans; Levodopa; Oligopeptides; Parkinson Disease; Receptors, Dopamine | 1979 |
Long-term treatment of Parkinson's disease with bromocriptine.
Topics: Adult; Age Factors; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1979 |
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan | 1979 |
Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Female; Humans; Kinetics; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |
[Myoclonic attacks induced by bromocriptine in Parkinsonian patients].
Topics: Bromocriptine; Catecholamines; Humans; Myoclonus; Parkinson Disease; Receptors, Drug | 1979 |
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.
Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Reticular Formation; Sleep | 1979 |
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.
Topics: Bromocriptine; Dopamine beta-Hydroxylase; Humans; Kinetics; Levodopa; Parkinson Disease | 1979 |
[Nycterohemeral variations of growth hormone and prolactin in 6 Parkinson's sufferers treated with bromocriptine (author's transl)].
Topics: Aged; Aging; Bromocriptine; Circadian Rhythm; Female; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Prolactin; Sex Factors; Sleep | 1979 |
Determination of bromocriptine in plasma: comparison of gas chromatography, mass fragmentography and liquid chromatography.
Topics: Bromocriptine; Chromatography, Gas; Chromatography, Liquid; Gas Chromatography-Mass Spectrometry; Humans; Parkinson Disease | 1979 |
Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
Topics: Animals; Apomorphine; Behavior; Bromocriptine; Dextroamphetamine; Guinea Pigs; Humans; Male; Parkinson Disease; Stereotyped Behavior | 1978 |
Bromocriptine in Parkinson disease: further studies.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1979 |
The role of bromocriptine in the treatment of parkinsonism.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1979 |
Bromocriptine: decreased clinical effects at higher dosages.
Topics: Bromocriptine; Humans; Parkinson Disease | 1979 |
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin | 1977 |
Treatment of Parkinson's disease with bromocriptine.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease | 1977 |
Bromocriptine--a versatile remedy.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Galactorrhea; Humans; Lactation Disorders; Parkinson Disease; Pregnancy | 1977 |
Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients.
Topics: Aged; Bromocriptine; Ergolines; Female; Gonadotropins, Pituitary; Growth Hormone; Humans; Male; Middle Aged; Parkinson Disease; Pituitary Hormones, Anterior; Thyrotropin | 1977 |
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
Topics: Aged; Benserazide; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease | 1977 |
Bromocriptine.
Topics: Acromegaly; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Parkinson Disease; Pregnancy; Pregnancy Complications | 1977 |
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.
Topics: Aged; Benzimidazoles; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease | 1978 |
Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.
Topics: Aged; Bromocriptine; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Parkinson Disease; Prolactin | 1978 |
[Bromocriptine (Parlodel) in parkinsonism].
Topics: Bromocriptine; Humans; Parkinson Disease | 1978 |
Role of ergot derivatives in the treatment of parkinsonism.
Topics: Acetonitriles; Animals; Bromocriptine; Disease Models, Animal; Ergolines; Humans; Liver; Parkinson Disease; Pyridines; Structure-Activity Relationship | 1978 |
Comparison between lergotrile and bromocriptine in parkinsonism.
Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1978 |
Bromocriptine in parkinsonism. A long-term study.
Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System | 1978 |
Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
Topics: Benserazide; Brain; Bromocriptine; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1978 |
Bromocriptine.
Topics: Acromegaly; Bromocriptine; Female; Humans; Parkinson Disease; Pregnancy; Prolactin | 1978 |
Bromocriptine in Parkinson's disease.
Topics: Bromocriptine; Humans; Levodopa; Parkinson Disease | 1978 |
EEG sleep study in parkinsonian patients under bromocryptine treatment.
Topics: Aged; Bromocriptine; Cerebral Cortex; Electroencephalography; Female; Humans; Male; Middle Aged; Parkinson Disease; Sleep | 1978 |
Overview of present day treatment of Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Receptors, Dopamine; Selegiline | 1978 |
Bromocriptine in lieu of levodopa for Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease | 1978 |
Brain dopamine turnover and the relief of parkinsonism.
Topics: Brain; Bromocriptine; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Parkinson Disease; Piperazines; Piribedil; Probenecid | 1977 |
Bromocriptine.
Topics: Acromegaly; Bromocriptine; Female; Humans; Hypogonadism; Lactation; Male; Parkinson Disease; Pregnancy; Prolactin | 1977 |
[Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
Topics: Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1977 |
Brain dopamine turnover and the relief of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Piperazines; Piribedil; Probenecid; Receptors, Dopamine | 1977 |
Treatment of parkinsonism.
Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1977 |
Studies with bromocriptine. Part 1. "On-off" phenomena.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Editorial: The many faces of bromocriptine.
Topics: Acromegaly; Bromocriptine; Ergolines; Female; Humans; Hypogonadism; Lactation; Lactation Disorders; Male; Parkinson Disease; Pregnancy | 1976 |
Letter: Platelet and coagulation studies in patients treated with bromocriptine.
Topics: Blood Coagulation; Bromocriptine; Ergolines; Female; Fibrinolysis; Humans; Male; Parkinson Disease; Platelet Aggregation | 1976 |
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex | 1976 |
Treatment of parkinson's disease with bromocriptine.
Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease | 1976 |
Developments in the treatment of parkinsonism.
Topics: Antiparkinson Agents; Bromocriptine; Drug Synergism; Ergolines; Humans; Parkinson Disease | 1976 |
[Neuroendocrine aspects of Parkinson's disease. Therapeutic/effect of a prolactin inhibitor].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Middle Aged; Parkinson Disease; Prolactin | 1976 |
Bromocriptine:dopamine-receptor agonist.
Topics: Acromegaly; Aged; Bromocriptine; Ergolines; Female; Humans; Infertility, Female; Parkinson Disease; Pituitary Neoplasms; Receptors, Dopamine | 1976 |
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine | 1976 |
[Treatment of Parkinson's disease with bromocriptine].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1976 |
Clinical studies with bromocriptine in idiopathic parkinsonism.
Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Parkinson Disease | 1976 |
[Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Topics: Aged; Bromocriptine; Drug Evaluation; Ergolines; Female; Humans; Male; Middle Aged; Parkinson Disease | 1976 |
Editorial: Alternatives to levodopa.
Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease | 1976 |
Bromocriptine - an important advance.
Topics: Acromegaly; Bromocriptine; Depression, Chemical; Ergolines; Female; Humans; Lactation; Parkinson Disease; Pregnancy; Prolactin | 1976 |
Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
Topics: Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion | 1992 |
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline.
Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agents; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline | 1992 |
[Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease].
Topics: Aged; Bromocriptine; Clozapine; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced | 1992 |
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Interactions; Female; Half-Life; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1992 |
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss | 1992 |
Acute respiratory failure from dopamine agonist withdrawal.
Topics: Acute Disease; Bromocriptine; Female; Humans; Middle Aged; Parkinson Disease; Respiratory Insufficiency; Substance Withdrawal Syndrome | 1992 |
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.
Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal | 1992 |
A component analysis of the generation and release of isometric force in Parkinson's disease.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl | 1992 |
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone | 1991 |
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Piribedil; Receptors, Adrenergic, beta | 1991 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin | 1990 |
The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease.
Topics: Aged; Bromocriptine; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1991 |
[Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment].
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Pleural Effusion | 1991 |
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl | 1991 |
[Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
Topics: Analysis of Variance; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1991 |
Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
Treating the progressive stages of Parkinson's disease.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline | 1991 |
Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome | 1991 |
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
Topics: Administration, Oral; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1991 |
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
Topics: Aged; Blood Pressure; Bromocriptine; Epinephrine; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture | 1991 |
Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy.
Topics: Bromocriptine; Female; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Skin Diseases | 1991 |
[Parkinson disease and photosensitive epilepsy].
Topics: Bromocriptine; Dopamine Antagonists; Electroencephalography; Epilepsies, Myoclonic; Humans; Light; Male; Middle Aged; Parkinson Disease | 1990 |
Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
Topics: Aged; Benserazide; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Serotonin | 1990 |
A view from inside.
Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease | 1990 |
[Pleural effusion induced by bromocriptine].
Topics: Aged; Bromocriptine; Humans; Male; Parkinson Disease; Pleural Effusion | 1990 |
[The treatment of Parkinson disease using the combination bromocriptine and levodopa].
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease | 1990 |
Parkinson disease: electrophysiological (CNV) analysis related to pharmacological treatment.
Topics: Bromocriptine; Contingent Negative Variation; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1986 |
[Retroperitoneal fibrosis after treatment by bromocriptine].
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis | 1989 |
[Retroperitoneal fibrosis after treatment with bromocriptine].
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis | 1989 |
Early dopamine agonist therapy in Parkinson's disease.
Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine | 1989 |
Concerns expressed about PATH program.
Topics: Advertising; Bromocriptine; Drug Industry; Humans; Nurse Practitioners; Parkinson Disease | 1989 |
The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson's disease.
Topics: Adjuvants, Pharmaceutic; Aged; Bromocriptine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1989 |
[A case of bromocriptine-induced interstitial pneumonitis in an iron factory worker exposed to sand dust].
Topics: Bromocriptine; Dust; Environmental Exposure; Humans; Iron; Male; Metallurgy; Middle Aged; Parkinson Disease; Pulmonary Fibrosis | 1989 |
[Bromocriptine].
Topics: Amenorrhea; Bromocriptine; Female; Humans; Male; Parkinson Disease | 1989 |
Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1989 |
Falls and Parkinson's disease.
Topics: Accidental Falls; Accidents; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Parkinson Disease; Physical Therapy Modalities; Posture; Risk Factors | 1989 |
Subcutaneous apomorphine in Parkinson's disease.
Topics: Apomorphine; Bromocriptine; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease | 1989 |
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echolalia; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease | 1989 |
Agonist substitution in advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Evaluation; Female; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors | 1989 |
[L-dopa, biperiden and sebum excretion in Parkinson disease].
Topics: Aged; Aged, 80 and over; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Sebum; Sex Factors | 1989 |
A community survey of Parkinson's disease.
Topics: Aged; British Columbia; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rural Population | 1989 |
[Bromocriptine and pulmonary responses].
Topics: Aged; Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Fibrosis; Radiography | 1989 |
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan | 1985 |
Retroperitoneal fibrosis and bromocriptine.
Topics: Bromocriptine; Humans; Hydronephrosis; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis | 1986 |
Parkinson's disease, depression, and the on-off phenomenon.
Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1989 |
Bromocriptine and pleuropulmonary disease.
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis | 1989 |
Comprehensive care of the patient with Parkinson's disease.
Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor | 1986 |
Progressive supranuclear palsy: nursing care implications.
Topics: Bromocriptine; Diagnosis, Differential; Humans; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Supranuclear Palsy, Progressive | 1988 |
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
Topics: Aged; Blood Platelets; Bromocriptine; Cell Membrane; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine | 1985 |
Function of dopamine receptors in Parkinson's disease: prolactin responses.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Time Factors | 1986 |
Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Bromocriptine; Dopamine; Drug Administration Schedule; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra; Time Factors | 1986 |
Chronic treatment with bromocriptine induces behavioral supersensitivity in rats.
Topics: Animals; Apomorphine; Bromocriptine; Dopamine Antagonists; Humans; Hydroxydopamines; Male; Oxidopamine; Parkinson Disease; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior | 1986 |
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease | 1986 |
Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses.
Topics: Bromocriptine; Corpus Striatum; Humans; Metoclopramide; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone | 1987 |
Current and future approaches to therapy.
Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline | 1987 |
Dopamine agonists as primary treatment in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine | 1987 |
Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Humans; Long-Term Care; Parkinson Disease | 1987 |
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
Topics: Aged; Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease | 1987 |
Parkinson's disease in the elderly: current management strategies.
Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1987 |
Bromocriptine induced impotence in Parkinson's disease.
Topics: Adult; Bromocriptine; Erectile Dysfunction; Humans; Male; Middle Aged; Parkinson Disease | 1987 |
Milestones in the development of modern Parkinson therapy.
Topics: 2,3-Diketogulonic Acid; Alloxan; Behavior; Bromocriptine; Drug Combinations; Drug Therapy, Combination; Ferric Compounds; Humans; Levodopa; Neurology; Parkinson Disease; Selegiline; Tryptophan | 1987 |
Drugs for parkinsonism.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline | 1988 |
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System | 1985 |
Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Ergolines; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Radiography | 1988 |
Pleuropulmonary involvement during bromocriptine treatment.
Topics: Aged; Bromocriptine; Humans; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion | 1988 |
Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease | 1988 |
International symposium on early dopamine agonist therapy of Parkinson's disease.
Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors | 1988 |
Lack of pharmacokinetic influence on levodopa by bromocriptine.
Topics: Bromocriptine; Carbidopa; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1988 |
[Pleuropulmonary changes during treatment with bromocriptine].
Topics: Aged; Bromocriptine; Humans; Lung; Male; Middle Aged; Parkinson Disease; Pleura | 1988 |
Outpatient treatment of Parkinson's disease.
Topics: Ambulatory Care; Benserazide; Bromocriptine; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Retrospective Studies | 1988 |
[Nursing homes patients with Parkinson disease: treatment].
Topics: Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nursing Homes; Parkinson Disease | 1988 |
Contractures of the extremities in parkinsonian subjects: a report of three cases with a possible association with bromocriptine treatment.
Topics: Bromocriptine; Contracture; Extremities; Female; Humans; Middle Aged; Parkinson Disease | 1988 |
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease].
Topics: Administration, Oral; Bromocriptine; Cerebrovascular Circulation; Female; Humans; Male; Middle Aged; Parkinson Disease | 1988 |
Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
Topics: Aged; Aged, 80 and over; Bromocriptine; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Levodopa; Middle Aged; Parkinson Disease | 1986 |
Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action.
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine | 1987 |
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
Topics: Administration, Oral; Aged; Bromocriptine; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Regional Blood Flow; Tomography, Emission-Computed | 1987 |
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
Topics: Bromocriptine; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Parkinson Disease | 1987 |
Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
Topics: Aged; Bromocriptine; Dementia; Female; Hallucinations; Humans; Parkinson Disease | 1987 |
Ocular motor and manual tracking in Parkinson's disease and the effect of treatment.
Topics: Adult; Aged; Bromocriptine; Eye Movements; Female; Hand; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Reaction Time; Saccades | 1987 |
Bromocriptine long acting (LA) 50 mg intramuscular (IM) for the on-off phenomenon in Parkinson's disease.
Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Parkinson Disease | 1987 |
[Neuropsychic side effects of bromocriptine in Parkinson's disease].
Topics: Aged; Bromocriptine; Cognition Disorders; Delusions; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1987 |
Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.
Topics: Aged; Bromocriptine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors | 1987 |
The use of bromocriptine in parkinsonism after carbon monoxide poisoning.
Topics: Adult; Aged; Bromocriptine; Carbon Monoxide Poisoning; Female; Humans; Male; Parkinson Disease | 1987 |
[Experience with the use of parlodel in the treatment of Parkinson patients].
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary | 1986 |
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor | 1986 |
Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Retroperitoneal Fibrosis | 1986 |
Pharmacotherapy: problems and practices.
Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.
Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin | 1986 |
Drugs for parkinsonism.
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1986 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
[Revision of the treatment strategy in Parkinson disease].
Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning | 1986 |
The drug treatment of parkinsonism.
Topics: Bromocriptine; Carboxy-Lyases; Dopamine; Humans; Levodopa; Parkinson Disease | 1986 |
Management of Parkinson's disease in general practice.
Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease | 1986 |
Cognitive performances in parkinsonians before and after bromocriptine therapy.
Topics: Aged; Bromocriptine; Cognition; Humans; Middle Aged; Parkinson Disease | 1986 |
Effect of antacid on levodopa therapy.
Topics: Aluminum Hydroxide; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Levodopa; Magnesium; Magnesium Hydroxide; Parkinson Disease | 1986 |
[Combination treatment in the early stages of Parkinson's disease].
Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease | 1987 |
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1987 |
Tracers for paralysis agitans in epidemiological research. IV. Trends in national drug policy and measurement of the prevalence of the disease in Sweden.
Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Antiparkinson Agents; Bromocriptine; Child; Child, Preschool; Drug Utilization; Epidemiologic Methods; Female; Humans; Infant; Infant Mortality; Levodopa; Male; Middle Aged; Parkinson Disease; Probability; Sweden; Time Factors | 1985 |
[Parlodel].
Topics: Bromocriptine; Humans; Parkinson Disease | 1985 |
Parkinson disease. Individualizing therapy.
Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor | 1985 |
Problems with inactivation of drugs used in Parkinson's disease.
Topics: Aged; Bromocriptine; Drug Stability; Female; Humans; Orphenadrine; Parkinson Disease; Suspensions | 1985 |
Pleuropulmonary reactions in patients on bromocriptine treatment.
Topics: Aged; Bromocriptine; Humans; Lung; Male; Parkinson Disease; Pleura; Pleurisy | 1986 |
Bromocriptine--an update.
Topics: Acromegaly; Bromocriptine; Female; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Kinetics; Lactation; Male; Nausea; Parkinson Disease; Pregnancy | 1986 |
[Dopaminergic agonists in Parkinson disease].
Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil | 1986 |
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine | 1985 |
Gynecological follow-up of parkinsonian patients on long-term bromocriptine treatment.
Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Middle Aged; Ovary; Parkinson Disease; Time Factors; Uterine Neoplasms; Uterus; Vagina; Vaginal Smears; Vulva | 1985 |
Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Dopamine agonists in the therapy of parkinson syndrome].
Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra | 1985 |
Bromocriptine dose and severity of Parkinson's disease.
Topics: Bromocriptine; Humans; Parkinson Disease | 1985 |
Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease.
Topics: Adult; Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1985 |
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl | 1985 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
Low-dose bromocriptine in Parkinson's disease.
Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease | 1985 |
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Clinical significance of long-term treatment of L-dopa with bromocriptine in parkinsonian patients who showed declining efficacy during L-dopa therapy].
Topics: Adult; Aged; Bromocriptine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 1985 |
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1985 |
Combined bromocriptine-levodopa therapy early in Parkinson's disease.
Topics: Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1985 |
The treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced | 1985 |
Pain in Parkinson's disease.
Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease | 1985 |
Controversies in the treatment of Parkinson's disease.
Topics: Bromocriptine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Time Factors | 1985 |
Parkinson's disease and hypertension: chronic bromocriptine treatment.
Topics: Aged; Bromocriptine; Domperidone; Female; Humans; Hypertension; Male; Parkinson Disease | 1985 |
[Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
Topics: Bromocriptine; Humans; Male; Middle Aged; Parkinson Disease; Pleural Diseases; Pulmonary Fibrosis | 1985 |
[Oral lisuride in Parkinson's disease].
Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease | 1985 |
Treatment of parkinsonism with bromocriptine.
Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease | 1974 |